デフォルト表紙
市場調査レポート
商品コード
973573

研究用抗体&試薬の世界市場:製品・技術 (ELISA・ウェスタンブロット法)・アプリケーション・エンドユーザー別 (2027年までの予測)

Research Antibodies & Reagents Market by Product {Antibodies [Type (Primary, Secondary), Production, Source, Research Area (Oncology, Neurology)], Reagents}, Technology (ELISA, Western Blot), Application, End User - Global Forecast to 2027

出版日: | 発行: Meticulous Market Research Pvt. Ltd. | ページ情報: 英文 272 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=128.85円
研究用抗体&試薬の世界市場:製品・技術 (ELISA・ウェスタンブロット法)・アプリケーション・エンドユーザー別 (2027年までの予測)
出版日: 2020年12月02日
発行: Meticulous Market Research Pvt. Ltd.
ページ情報: 英文 272 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界における研究用抗体&試薬の市場規模は、2020年から2027年にかけて、5.6%のCAGRで成長すると見込まれ、2027年までに63億2000万米ドルへ達すると予測されています。

プロテオミクスおよびゲノミクスの研究研究の増加、研究活動への資金提供の増加、産学連携の拡大が主な推進要因です。さらに、タンパク質治療薬と個別化医療の需要の高まり、幹細胞調査への投資の増加、バイオマーカーの同定の必要性の高まりなどの要因は、市場参入企業にとって予測期間中の高い成長機会を表しています。ただし、潜在的な抗体の識別および開発に関連する高コストおよび時間の長さといった要因は、同市場の成長を妨げると予想されます。

当レポートでは、研究用抗体&試薬の世界市場について調査分析し、市場の概要、各セグメント・地域別の市場動向、市場規模の推移と予測、市場促進要因および阻害要因の分析、市場の将来展望、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

第1章 イントロダクション

  • 市場エコシステム
    • 研究用抗体&試薬市場
    • 研究用抗体&試薬市場:製品別
  • 通貨と制限
    • 通貨
    • 制限事項
  • 主要ステークホルダ

第2章 調査手法

  • 調査プロセス
    • 2次調査
    • 1次調査

第3章 エグゼクティブサマリー

第4章 市場の考察

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題

第5章 研究用抗体&試薬市場:製品別

  • イントロダクション
  • 抗体
    • 抗体市場:タイプ別
    • 抗体市場:生産タイプ別
    • 抗体市場:原料別
    • 抗体市場:研究分野別
  • 試薬
    • サンプル調製試薬
    • 抗体産生試薬
    • その他の調査試薬

第6章 研究用抗体&試薬市場:技術別

  • イントロダクション
  • フローサイトメトリー
  • 免疫蛍光
  • 酵素免疫測定法 (ELISA)
  • 免疫沈降 (IP)
  • マルチプレックス免疫吸着測定法
  • 免疫組織化学
  • ウエスタンブロット法
  • その他の技術

第7章 研究用抗体&試薬市場:アプリケーション別

  • イントロダクション
  • プロテオミクス
  • 創薬&開発
  • ゲノミクス

第8章 研究用抗体&試薬市場:エンドユーザー別

  • イントロダクション
  • 医薬品&バイオテクノロジー業界
  • 大学&研究機関
  • 委託調査機関 (CRO)

第9章 研究用抗体&試薬市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • その他アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

  • イントロダクション
  • 主要な成長戦略
  • 競合ベンチマーキング
  • 市場シェア分析

第11章 企業プロファイル

  • GE Healthcare
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Rockland Immunochemicals Inc.
  • Johnson & Johnson (J&J)
  • Eli Lilly and Company
  • Teva Pharmaceutical industries Limited
  • Abcam Plc
  • Agilent Technologies, Inc.
  • Cell Signaling Technology, Inc.
  • Becton Dickinson and Company
  • Danaher Corporation
  • Lonza
  • PerkinElmer、Inc。
  • GenScript Biotech Corporation
  • Bio-Techne Corporation
  • Bio-Rad Laboratories, Inc.
  • Santa Cruz Biotechnology, Inc.
  • Biolegend, Inc.

第12章 付録

図表

List of Tables

  • Table 1 Global Research Antibodies and Reagents Market Drivers: Impact Analysis (2019-2025)
  • Table 2 Global Research Antibodies and Reagents Market Restraint: Impact Analysis (2019-2025)
  • Table 3 Global Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
  • Table 4 Global Research Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 5 Global Research Antibodies Market Size, by Type, 2018-2027 ($Million)
  • Table 6 Global Primary Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 7 Global Secondary Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 8 Global Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
  • Table 9 Global Monoclonal Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 10 Global Polyclonal Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 11 Global Antibody Fragments Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 12 Global Research Antibodies Market Size, by Source, 2018-2027 ($Million)
  • Table 13 Global Mouse Derived Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 14 Global Rabbit Derived Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 15 Global Other Sources Derived Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 16 Global Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
  • Table 17 Global Research Antibodies Market Size for Oncology, by Country/Region, 2018-2027 ($Million)
  • Table 18 Global Research Antibodies Market Size for Infectious Diseases, by Country/Region, 2018-2027 ($Million)
  • Table 19 Global Research Antibodies Market Size for Cardiovascular Diseases, by Country/Region, 2018-2027 ($Million)
  • Table 20 Global Research Antibodies Market Size for Immunology, by Country/Region, 2018-2027 ($Million)
  • Table 21 Global Research Antibodies Market Size for Neurology, by Country/Region, 2018-2027 ($Million)
  • Table 22 Global Research Antibodies Market Size for Stem Cell Research, by Country/Region, 2018-2027 ($Million)
  • Table 23 Global Research Antibodies Market Size for Other Research Areas, by Country/Region, 2018-2027 ($Million)
  • Table 24 Global Research Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 25 Global Research Reagents Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 26 Global Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 27 Global Sample Preparation Reagents Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 28 Global Media and Serum Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 29 Global Stains and Dyes Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 30 Global Probes Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 31 Global Buffers Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 32 Global Solvents Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 33 Global Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 34 Global Antibody Production Reagents Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 35 Global Enzymes Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 36 Global Proteins Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 37 Global Other Research Reagents Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 38 Global Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
  • Table 39 Global Research Antibodies and Reagents Market Size for Flow Cytometry, by Country/Region, 2018-2027 ($Million)
  • Table 40 Global Research Antibodies and Reagents Market Size for Immunofluorescence, by Country/Region, 2018-2027 ($Million)
  • Table 41 Global Research Antibodies and Reagents Market Size for Enzyme-Linked Immunosorbent Assay, by Country/Region, 2018-2027 ($Million)
  • Table 42 Global Research Antibodies and Reagents Market Size for Immunoprecipitation, by Country/Region, 2018-2027 ($Million)
  • Table 43 Global Multiplex Immunosorbent Assay Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 44 Global Research Antibodies and Reagents Market Size for Immunohistochemistry, by Country/Region, 2018-2027 ($Million)
  • Table 45 Global Research Antibodies and Reagents Market Size for Western Blot, by Country/Region, 2018-2027 ($Million)
  • Table 46 Global Research Antibodies and Reagents Market Size for Other Technologies, by Country/Region, 2018-2027 ($Million)
  • Table 47 Global Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
  • Table 48 Global Research Antibodies and Reagents Market Size for Proteomics, by Country/Region, 2018-2027 ($Million)
  • Table 49 Global Research Antibodies and Reagents Market Size for Drug Discovery and Development, by Country/Region, 2018-2027 ($Million)
  • Table 50 Global Research Antibodies and Reagents Market Size for Genomics, by Country/Region, 2018-2027 ($Million)
  • Table 51 Global Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
  • Table 52 Global Research Antibodies and Reagents Market Size for Pharmaceutical and Biotechnology Industry, by Country/Region, 2018-2027 ($Million)
  • Table 53 Global Research Antibodies and Reagents Market Size for Academic and Research Institutes, by Country/Region, 2018-2027 ($Million)
  • Table 54 Global Research Antibodies and Reagents Market Size for Contract Research Organizations, by Country/Region, 2018-2027 ($Million)
  • Table 55 Global Research Antibodies and Reagents Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 56 North America: Research Antibodies and Reagents Market Size, by Country, 2018-2027 ($Million)
  • Table 57 North America: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
  • Table 58 North America: Research Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 59 North America: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 60 North America: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 61 North America: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
  • Table 62 North America: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
  • Table 63 North America: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
  • Table 64 North America: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
  • Table 65 North America: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
  • Table 66 North America: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
  • Table 67 North America: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
  • Table 68 U.S.: Key Macroindicators
  • Table 69 U.S.: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
  • Table 70 U.S.: Research Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 71 U.S.: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 72 U.S.: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 73 U.S.: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
  • Table 74 U.S.: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
  • Table 75 U.S.: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
  • Table 76 U.S.: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
  • Table 77 U.S.: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
  • Table 78 U.S.: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
  • Table 79 U.S.: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
  • Table 80 Canada: Key Macroindicators
  • Table 81 Canada: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
  • Table 82 Canada: Research Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 83 Canada: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 84 Canada: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 85 Canada: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
  • Table 86 Canada: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
  • Table 87 Canada: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
  • Table 88 Canada: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
  • Table 89 Canada: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
  • Table 90 Canada: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
  • Table 91 Canada: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
  • Table 92 Europe: Research Antibodies and Reagents Market Size, by Country, 2018-2027 ($Million)
  • Table 93 Europe: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
  • Table 94 Europe: Research Reagents Market Size, by Type, 2018-2027($Million)
  • Table 95 Europe: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
  • Table 96 Europe: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
  • Table 97 Europe: Research Antibodies Market Size, by Type, 2018-2027($Million)
  • Table 98 Europe: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
  • Table 99 Europe: Research Antibodies Market Size, by Source, 2018-2027($Million)
  • Table 100 Europe: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
  • Table 101 Europe: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
  • Table 102 Europe: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
  • Table 103 Europe: Research Antibodies and Reagents Market Size, by End User, 2018-2027($Million)
  • Table 104 Germany: Key Macroindicators
  • Table 105 Germany: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
  • Table 106 Germany: Research Reagents Market Size, by Type, 2018-2027($Million)
  • Table 107 Germany: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
  • Table 108 Germany: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
  • Table 109 Germany: Research Antibodies Market Size, by Type, 2018-2027($Million)
  • Table 110 Germany: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
  • Table 111 Germany: Research Antibodies Market Size, by Source, 2018-2027($Million)
  • Table 112 Germany: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
  • Table 113 Germany: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
  • Table 114 Germany: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
  • Table 115 Germany: Research Antibodies and Reagents Market Size, by End User, 2018-2027($Million)
  • Table 116 France: Key Macroindicators
  • Table 117 France: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
  • Table 118 France: Research Reagents Market Size, by Type, 2018-2027($Million)
  • Table 119 France: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
  • Table 120 France: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
  • Table 121 France: Research Antibodies Market Size, by Type, 2018-2027($Million)
  • Table 122 France: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
  • Table 123 France: Research Antibodies Market Size, by Source, 2018-2027($Million)
  • Table 124 France: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
  • Table 125 France: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
  • Table 126 France: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
  • Table 127 France: Research Antibodies and Reagents Market Size, by End User, 2018-2027($Million)
  • Table 128 U.K.: Key Macroindicators
  • Table 129 U.K.: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
  • Table 130 U.K.: Research Reagents Market Size, by Type, 2018-2027($Million)
  • Table 131 U.K.: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
  • Table 132 U.K.: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
  • Table 133 U.K.: Research Antibodies Market Size, by Type, 2018-2027($Million)
  • Table 134 U.K.: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
  • Table 135 U.K.: Research Antibodies Market Size, by Source, 2018-2027($Million)
  • Table 136 U.K.: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
  • Table 137 U.K.: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
  • Table 138 U.K.: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
  • Table 139 U.K.: Research Antibodies and Reagents Market Size, by End User, 2018-2027($Million)
  • Table 140 Italy: Key Macroindicators
  • Table 141 Italy: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
  • Table 142 Italy: Research Reagents Market Size, by Type, 2018-2027($Million)
  • Table 143 Italy: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
  • Table 144 Italy: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
  • Table 145 Italy: Research Antibodies Market Size, by Type, 2018-2027($Million)
  • Table 146 Italy: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
  • Table 147 Italy: Research Antibodies Market Size, by Source, 2018-2027($Million)
  • Table 148 Italy: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
  • Table 149 Italy: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
  • Table 150 Italy: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
  • Table 151 Italy: Research Antibodies and Reagents Market Size, by End User, 2018-2027($Million)
  • Table 152 Spain: Key Macroindicators
  • Table 153 Spain: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
  • Table 154 Spain: Research Reagents Market Size, by Type, 2018-2027($Million)
  • Table 155 Spain: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
  • Table 156 Spain: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
  • Table 157 Spain: Research Antibodies Market Size, by Type, 2018-2027($Million)
  • Table 158 Spain: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
  • Table 159 Spain: Research Antibodies Market Size, by Source, 2018-2027($Million)
  • Table 160 Spain: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
  • Table 161 Spain: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
  • Table 162 Spain: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
  • Table 163 Spain: Research Antibodies and Reagents Market Size, by End User, 2018-2027($Million)
  • Table 164 RoE: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
  • Table 165 RoE: Research Reagents Market Size, by Type, 2018-2027($Million)
  • Table 166 RoE: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
  • Table 167 RoE: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
  • Table 168 RoE: Research Antibodies Market Size, by Type, 2018-2027($Million)
  • Table 169 RoE: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
  • Table 170 RoE: Research Antibodies Market Size, by Source, 2018-2027($Million)
  • Table 171 RoE: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
  • Table 172 RoE: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
  • Table 173 RoE: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
  • Table 174 RoE: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
  • Table 175 Asia Pacific: Research Antibodies and Reagents Market Size, by Country, 2018-2027 ($Million)
  • Table 176 Asia-Pacific: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
  • Table 177 Asia-Pacific: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
  • Table 178 Asia-Pacific: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
  • Table 179 Asia-Pacific: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
  • Table 180 Asia-Pacific: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
  • Table 181 Asia-Pacific: Research Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 182 Asia-Pacific: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 183 Asia-Pacific: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 184 Asia-Pacific: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
  • Table 185 Asia-Pacific: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
  • Table 186 Asia-Pacific: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
  • Table 187 Japan: Key Macroindicators
  • Table 188 Japan: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
  • Table 189 Japan: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
  • Table 190 Japan: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
  • Table 191 Japan: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
  • Table 192 Japan: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
  • Table 193 Japan: Research Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 194 Japan: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 195 Japan: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 196 Japan: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
  • Table 197 Japan: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
  • Table 198 Japan: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
  • Table 199 China: Key Macroindicators
  • Table 200 China: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
  • Table 201 China: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
  • Table 202 China: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
  • Table 203 China: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
  • Table 204 China: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
  • Table 205 China: Research Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 206 China: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 207 China: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 208 China: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
  • Table 209 China: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
  • Table 210 China: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
  • Table 211 India: Key Macroindicators
  • Table 212 India: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
  • Table 213 India: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
  • Table 214 India: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
  • Table 215 India: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
  • Table 216 India: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
  • Table 217 India: Research Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 218 India: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 219 India: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 220 India: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
  • Table 221 India: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
  • Table 222 India: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
  • Table 223 Rest of Asia-Pacific: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
  • Table 224 Rest of Asia-Pacific: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
  • Table 225 Rest of Asia-Pacific: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
  • Table 226 Rest of Asia-Pacific: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
  • Table 227 Rest of Asia-Pacific: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
  • Table 228 Rest of Asia-Pacific: Research Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 229 Rest of Asia-Pacific: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 230 Rest of Asia-Pacific: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 231 Rest of Asia-Pacific: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
  • Table 232 Rest of Asia-Pacific: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
  • Table 233 Rest of Asia-Pacific: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
  • Table 234 Latin America: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
  • Table 235 Latin America: Research Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 236 Latin America: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 237 Latin America: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 238 Latin America: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
  • Table 239 Latin America: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
  • Table 240 Latin America: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
  • Table 241 Latin America: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
  • Table 242 Latin America: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
  • Table 243 Latin America: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
  • Table 244 Latin America: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
  • Table 245 Middle East & Africa: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
  • Table 246 Middle East & Africa: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
  • Table 247 Middle East & Africa: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
  • Table 248 Middle East & Africa: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
  • Table 249 Middle East & Africa: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
  • Table 250 Middle East & Africa: Research Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 251 Middle East & Africa: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 252 Middle East & Africa: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
  • Table 253 Middle East & Africa: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
  • Table 254 Middle East & Africa: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
  • Table 255 Middle East & Africa: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
  • Table 256 Number of Developments by the Major Players during 2016-2019

List of Figures

  • Figure 1 Research Process
  • Figure 2 Key Executives Interviewed
  • Figure 3 Primary Research Techniques
  • Figure 4 Market Size Estimation
  • Figure 5 Reagents Dominate the Global Research Antibodies and Reagents Market
  • Figure 6 Global Research Antibodies and Reagents Market, by Technology, 2020-2027 ($Million)
  • Figure 7 Global Research Antibodies and Reagents Market, by Application, 2020-2027 ($Million)
  • Figure 8 Pharmaceutical and Biotechnology Industry Segment Is Expected to Be a Prominent End User for Research Antibodies and Reagents Market
  • Figure 9 Research Antibodies and Reagents Market, by Region
  • Figure 10 Rate of Publication Related to Genomics, Proteomics or Metabolomics (2008-2016)
  • Figure 11 Share of Medical and Health R&D Expenditure of U.S. by Type of organization: 2017
  • Figure 12 Number of Therapeutic Proteins Approved Globally, 2012-2015
  • Figure 13 NIH Spending on Stem Cell Research in the U.S. (2013-2016)
  • Figure 14 Number of New Cancer Cases, Globally: 2012-2040
  • Figure 15 Proportion of Population Aged 60 or Over in Asia, by Region, 2016-2050
  • Figure 16 Monoclonal Antibody Approval Rate (2008-2015)
  • Figure 17 Global Research Antibodies and Reagents Market Size, by Product, 2020-2027 ($Million)
  • Figure 18 Number of Cancer Cases and Deaths, Globally: 2018-2040
  • Figure 19 Global Number of People Living with HIV in 2017 (In Millions)
  • Figure 20 Number of Deaths Attributed to Cardiovascular Disease Globally, 2013-2030 (In Millions)
  • Figure 21 Global Research Antibodies and Reagents Market Size, by Technology, 2020-2027 ($Million)
  • Figure 22 Global Research Antibodies and Reagents Market Size, by Application, 2020-2027 ($Million)
  • Figure 23 Number of Biologics Approved by the U.S. FDA: 2010-2018
  • Figure 24 Global Research Antibodies and Reagents Market Size, by End User, 2020-2027 ($Million)
  • Figure 25 Global Research Antibodies and Reagents Market Size, by Geography, 2020-2027 ($Million)
  • Figure 26 Number of Geriatric Population (65 Years & Above) in the U.S., 2010-2060 (Millions)
  • Figure 27 North America: Research Antibodies and Reagents Market Snapshot
  • Figure 28 Number of People with Chronic Diseases in America.: 2005-2030 (Million)
  • Figure 29 Pharma Member Company R&D Expenditure in the U.S., 2011-2017 ($Billion)
  • Figure 30 Cancer Cases in Canada: 2018-2040
  • Figure 31 Population Aged 60 or Over in Europe: 2017 and 2050
  • Figure 32 Health Spending ($/Capita), by Eu5 Countries- 2018
  • Figure 33 Europe: Research Antibodies and Reagents Market Size, by Country, 2020-2027 ($Million)
  • Figure 34 Biotechnology Firms in Germany: 2010-2017
  • Figure 35 Share of Population Aged 65 & Above In Total Population in France: 2010-2018
  • Figure 36 Number of New Cancer Cases and Mortality in the U.K.: 2018-2040
  • Figure 37 Number of Biotech Firms in Italy: 2008-2017
  • Figure 38 Cancer Incidence by Country: 2018-2040 (Number of Cases)
  • Figure 39 Asia-Pacific: Research Antibodies and Reagents Market Snapshot
  • Figure 40 Population Aged 60 or Over in Japan (As % of Total Population): 2000-2030
  • Figure 41 Cancer Incidence in Latin America & Caribbean, 2018-2040 (Number of Cases)
  • Figure 42 Cancer Incidence in the Middle East and Africa: 2012 and 2030
  • Figure 43 Key Growth Strategies Adopted by Leading Players, 2016-2019
  • Figure 44 Research Antibodies and Reagents Market: Competitive Benchmarking
  • Figure 45 Global Research Antibodies Market Share, by Key Player, 2018
  • Figure 46 GE Healthcare: Financial Overview (2016-2018)
  • Figure 47 Merck & Co., Inc.: Financial Overview (2016-2018)
  • Figure 48 Thermo Fisher Scientific Inc.: Financial Overview (2016-2018)
  • Figure 49 F. Hoffmann-La Roche Ltd: Financial Overview (2016-2018)
  • Figure 50 Johnson & Johnson: Financial Overview (2016-2018)
  • Figure 51 Eli Lilly and Company: Financial Overview (2016-2018)
  • Figure 52 Teva Pharmaceuticals Industries Limited: Financial Overview (2016-2018)
  • Figure 53 Abcam Plc: Financial Overview (2017-2019)
  • Figure 54 Agilent Technologies, Inc.: Financial Overview (2016-2018)
  • Figure 55 Becton, Dickinson and Company: Financial Overview (2016-2018)
  • Figure 56 Danaher Corporation: Financial Overview (2016-2018)
  • Figure 57 Lonza: Financial Overview (2016-2018)
  • Figure 58 PerkinElmer, Inc.: Financial Overview (2016-2018)
  • Figure 59 GenScript Biotech Corporation: Financial Overview (2016-2018)
  • Figure 60 Bio-Techne Corporation: Financial Overview (2017-2019)
  • Figure 61 Bio-Rad Laboratories, Inc.: Financial Overview (2016-2018)
目次

Research Antibodies and Reagents Market by Product {Antibodies [Type (Primary, Secondary), Production, Source, Research Area (Oncology, Neurology)], Reagents}, Technology (ELISA, Western Blot), Application, End User (Pharma, Academia) - Global Forecast to 2027

The research antibodies and reagents market is expected to grow at a CAGR of 5.6% from 2020 to 2027 to reach USD 6.32 billion by 2027.

Succeeding an extensive secondary and primary research and in-depth analysis of the market scenario, the report carries out the key industry drivers, restraints, trends, and opportunities. Increasing proteomics and genomics research studies, increasing funding for research activities, and growing industry-academia collaborations are the main driving factors. Furthermore, factors such as rising demand for protein therapeutics & personalized medicine, increasing investment in stem cell research, and rising need for biomarker identification represent high-growth opportunities for players during the forecast period. However, factors such as high cost and time related to identifying and developing potential antibodies are expected to hinder the growth of this market.

In 2020, based on type, the antibodies segment is projected to account for the largest share of this market. The large share of this segment is mainly attributed to increasing demand for antibodies for biomedical research, growing focus on protein and cell-based research, and increasing number of biomarker discovery.

On the basis of technology, in 2020, the flow cytometry segment is poised to command the largest share of the research antibodies and reagents market. The raising biomedical research for better diagnosis and therapy, initiatives for rising biomarker discovery, and growing cell & molecular-based research are the factors driving this growth of this segment.

In 2020, the proteomics segment is expected to command the largest share of the research antibodies and reagents market. Growing focus on protein-based research and the rising need for effective drugs using various protein-based disease profiling are the factors driving the growth of this segment.

The pharmaceutical and biotechnology industry is widely adopting research antibodies and reagents for proteomics research and drug discovery and development.

An in-depth analysis of the geographical scenario of the research antibodies and reagents market provides detailed qualitative and quantitative insights for the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2020, North America is estimated to command the largest share of the research antibodies and reagents market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The key players operating in the research antibodies and reagents market are GE Healthcare (U.S.), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann La-Roche AG (Switzerland), Rockland Immunochemicals Inc. (U.S.), Johnson & Johnson (U.S.), Agilent Technologies, Inc. (U.S.), Eli Lily and Company (U.S.), Becton Dickinson and Company (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), GenScript Biotech Corporation (U.S.), Lonza (Switzerland), Bio-Techne Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Teva Pharmaceutical Industries Limited (Israel), Santa Cruz Biotechnology, Inc. (U.S.), and BioLegend, Inc. (U.S.).

Scope of the Report:

Research Antibodies and Reagents Market, by Product Type

  • Antibodies
    • Antibodies Market, by Type
  • Primary Antibody
  • Secondary Antibody
    • Antibodies Market, by Production Type
  • Monoclonal Antibody
  • Polyclonal Antibody
  • Antibody Fragments
    • Antibodies Market, by Source
  • Mouse
  • Rabbit
  • Others
    • Antibodies Market, by Research Area
  • Oncology
  • Infectious Diseases
  • Cardiovascular Disease
  • Immunology
  • Neurology
  • Stem Cell Research
  • Others
  • Reagents
    • Sample Preparation Reagents
  • Media and Serum
  • Stain and Dyes
  • Probes
  • Buffers
  • Solvents
    • Antibody Production Reagents
  • Enzymes
  • Proteins
    • Other Research Reagents

Research Antibodies and Reagents Market, by Technology

  • Western Blot
  • Immunofluorescence
  • Enzyme-Linked Immunosorbent Assay
  • Multiplex Immunosorbent Assay
  • Flow Cytometry
  • Immunohistochemistry
  • Immunoprecipitation (IP)
  • Others

Research Antibodies and Reagents Market, by Application

  • Proteomics
  • Drug Discovery and Development
  • Genomics

Research Antibodies and Reagents Market, by End User

  • Pharmaceutical and Biotechnology Industry
  • Academic and Research Institutes
  • Contract Research Organizations

Research Antibodies and Reagents Market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia Pacific
  • Japan
  • China
  • India
  • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Market Ecosystem
    • 1.1.1. Research Antibodies and Reagents Market
    • 1.1.2. Research Antibodies and Reagents Market, by Product
  • 1.2. Currency and Limitations
    • 1.2.1. Currency
    • 1.2.2. Limitations
  • 1.3. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Secondary Research
    • 2.1.2. Primary Research

3. Executive Summary

4. Market insights

  • 4.1. Introduction
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
      • 4.2.1.1. Rising Proteomics and Genomics Research Studies
      • 4.2.1.2. Increase in the Funding for Research Activities
      • 4.2.1.3. Growing Industry-Academia Collaboration
    • 4.2.2. Restraint
      • 4.2.2.1. High Cost and Time Related to Identification and Development of Potential Antibodies
    • 4.2.3. Opportunities
      • 4.2.3.1. Rising Demand for Protein Therapeutics and Personalized Medicines
      • 4.2.3.2. Rising Investment and Focus on Stem-Cell Research
      • 4.2.3.3. Rising Need for New Biomarker Identification
      • 4.2.3.4. Significant Opportunities from Emerging Asia-Pacific and Latin-American Markets
    • 4.2.4. Challenges
      • 4.2.4.1. Issues Related to Quality and Stability of Research Antibodies
      • 4.2.4.2. Intense Pricing Pressure on Leading Players

5. Research Antibodies and Reagents Market, by Product

  • 5.1. Introduction
  • 5.2. Antibodies
    • 5.2.1. Antibodies Market, by Type
      • 5.2.1.1. Primary Antibodies
      • 5.2.1.2. Secondary Antibody
    • 5.2.2. Antibodies Market, by Production Type
      • 5.2.2.1. Monoclonal Antibody
      • 5.2.2.2. Polyclonal Antibody
      • 5.2.2.3. Antibody Fragments
    • 5.2.3. Antibody Market, by Source
      • 5.2.3.1. Mouse
      • 5.2.3.2. Rabbit
      • 5.2.3.3. Other Sources
    • 5.2.4. Antibodies Market, by Research Area
      • 5.2.4.1. Oncology
      • 5.2.4.2. Infectious Diseases
      • 5.2.4.3. Cardiovascular Disease
      • 5.2.4.4. Immunology
      • 5.2.4.5. Neurology
      • 5.2.4.6. Stem Cell Research
      • 5.2.4.7. Other Research Areas
  • 5.3. Reagents
    • 5.3.1. Sample Preparation Reagents
      • 5.3.1.1. Media and Serum
      • 5.3.1.2. Stains and Dyes
      • 5.3.1.3. Probes
      • 5.3.1.4. Buffers
      • 5.3.1.5. Solvents
    • 5.3.2. Antibody Production Reagents
      • 5.3.2.1. Enzymes
      • 5.3.2.2. Proteins
    • 5.3.3. Other Research Reagents

6. Research Antibodies and Reagents Market, by Technology

  • 6.1. Introduction
  • 6.2. Flow Cytometry
  • 6.3. Immunofluorescence
  • 6.4. Enzyme-Linked Immunosorbent Assay
  • 6.5. Immunoprecipitation (IP)
  • 6.6. Multiplex Immunosorbent Assay
  • 6.7. Immunohistochemistry
  • 6.8. Western Blot
  • 6.9. Other Technologies

7. Research Antibodies and Reagents Market, by Application

  • 7.1. Introduction
  • 7.2. Proteomics
  • 7.3. Drug Discovery and Development
  • 7.4. Genomics

8. Research Antibodies and Reagents Market, by End User

  • 8.1. Introduction
  • 8.2. Pharmaceutical and Biotechnology Industry
  • 8.3. Academic and Research Institutes
  • 8.4. Contract Research Organizations

9. Research Antibodies and Reagents Market, by Geography

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. Japan
    • 9.4.2. China
    • 9.4.3. India
    • 9.4.4. Rest of Asia-Pacific
  • 9.5. Latin America
  • 9.6. Middle East & Africa

10. Competitive Landscape

  • 10.1. Introduction
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Market Share Analysis

11. Company Profiles

  • 11.1. GE Healthcare
    • 11.1.1. Business Overview
    • 11.1.2. Financial Overview
    • 11.1.3. Product Portfolio
  • 11.2. Merck KGaA
    • 11.2.1. Business Overview
    • 11.2.2. Financial Overview
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Developments
  • 11.3. Thermo Fisher Scientific Inc.
    • 11.3.1. Business Overview
    • 11.3.2. Financial Overview
    • 11.3.3. Product Portfolio
    • 11.3.4. Strategic Developments
  • 11.4. F. Hoffmann-La Roche Ltd
    • 11.4.1. Business Overview
    • 11.4.2. Financial Overview
    • 11.4.3. Product Portfolio
  • 11.5. Rockland Immunochemicals Inc.
    • 11.5.1. Business Overview
    • 11.5.2. Product Portfolio
  • 11.6. Johnson & Johnson (J&J)
    • 11.6.1. Business Overview
    • 11.6.2. Financial Overview
    • 11.6.3. Product Portfolio
  • 11.7. Eli Lilly and Company
    • 11.7.1. Business Overview
    • 11.7.2. Financial Overview
    • 11.7.3. Product Portfolio
  • 11.8. Teva Pharmaceutical industries Limited
    • 11.8.1. Business Overview
    • 11.8.2. Financial Overview
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Developments
  • 11.9. Abcam Plc
    • 11.9.1. Business Overview
    • 11.9.2. Financial Overview
    • 11.9.3. Product Portfolio
    • 11.9.4. Strategic Developments
  • 11.10. Agilent Technologies, Inc.
    • 11.10.1. Business Overview
    • 11.10.2. Financial Overview
    • 11.10.3. Product Portfolio
  • 11.11. Cell Signaling Technology, Inc.
    • 11.11.1. Business Overview
    • 11.11.2. Product Portfolio
    • 11.11.3. Strategic Developments
  • 11.12. Becton Dickinson and Company
    • 11.12.1. Business Overview
    • 11.12.2. Financial Overview
    • 11.12.3. Product Portfolio
  • 11.13. Danaher Corporation
    • 11.13.1. Business Overview
    • 11.13.2. Financial Overview
    • 11.13.3. Product Portfolio
  • 11.14. Lonza
    • 11.14.1. Business Overview
    • 11.14.2. Financial Overview
    • 11.14.3. Product Portfolio
    • 11.14.4. Strategic Development
  • 11.15. PerkinElmer, Inc.
    • 11.15.1. Business Overview
    • 11.15.2. Financial Overview
    • 11.15.3. Product Portfolio
    • 11.15.4. Strategic Developments
  • 11.16. GenScript Biotech Corporation
    • 11.16.1. Business Overview
    • 11.16.2. Financial Overview
    • 11.16.3. Product Portfolio
    • 11.16.4. Strategic Developments
  • 11.17. Bio-Techne Corporation
    • 11.17.1. Business Overview
    • 11.17.2. Financial Overview
    • 11.17.3. Product Portfolio
    • 11.17.4. Strategic Developments
  • 11.18. Bio-Rad Laboratories, Inc.
    • 11.18.1. Business Overview
    • 11.18.2. Financial Overview
    • 11.18.3. Product Portfolio
    • 11.18.4. Strategic Developments
  • 11.19. Santa Cruz Biotechnology, Inc.
    • 11.19.1. Business Overview
    • 11.19.2. Product Portfolio
  • 11.20. Biolegend, Inc.
    • 11.20.1. Business Overview
    • 11.20.2. Product Portfolio
    • 11.20.3. Strategic Developments

12. Appendix

  • 12.1. Questionnaire
  • 12.2. Available Customization